Keith G. Haddaway, Ph.D.

Keith's practice encompasses life sciences (pharmaceuticals, diagnostic methods, and medical devices); commercial chemicals (polymers, coatings, catalysts, and petroleum additives); and consumer products (dietary supplements, nutraceuticals, and cosmetics); and design patents. He provides technical and legal understanding of regulatory and business practices necessary for interacting with government agencies, and for obtaining financing, conducting internal due diligence, and mergers and acquisitions.

Keith's services include:

• Patent drafting and prosecution
• Worldwide portfolio management and strategic development, licensing, and litigation
• Preparing patentability opinions, patent infringement analyses, and freedom-to-operate opinions
• Structuring, drafting, and negotiating licenses, partnering agreements, and joint development arrangements

Keith understands how technology and intellectual property can be used to advance clients' business goals. He frequently lends his scientific and IP knowledge to other practices within the firm, providing critical guidance to attorneys working on environmental, Food and Drug Administration (FDA), Federal Trade Commission (FTC), and export control matters. He also assists corporate attorneys with such issues as interaction with government agencies, financing, internal due diligence, and mergers and acquisitions.

Prior to practicing law, Keith spent more than 10 years conducting basic and applied research in diverse areas of organic photochemistry, color additive technology at the Food and Drug Administration, chemical defense with the Department of Defense, and chemical analysis and methods development. He reviewed chemicals for the EPA under the Toxic Substances Control Act (TSCA) and has several years of experience teaching at the college level.